by The Antimicrobial Susceptibility Testing Market consists of laboratory testing methods and analyses to determine the susceptibility of microorganisms to antimicrobial drugs. These tests play a crucial role in diagnosing infectious diseases and providing effective treatment by determining the optimal antibiotic therapy.
The global Antimicrobial Susceptibility Testing Market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising antibiotic resistance has been propelling the expansion of the antimicrobial susceptibility testing market. According to the World Health Organization (WHO), antibiotic resistance is growing exponentially, threatening global health security. The misuse and overuse of antibiotics have accelerated the emergence of resistance, complicating the treatment of infectious diseases. By identifying effective and optimal antibiotic therapy for resistant infections through antimicrobial susceptibility testing, healthcare providers can optimize antibiotic use and clinical outcomes. This is expected to drive the demand for these tests significantly over the forecast period. Advanced technologies such as molecular diagnostic tests for rapid detection of resistance genes are also aiding the antimicrobial susceptibility testing market growth.
SWOT Analysis
Strength: Antimicrobial susceptibility testing helps clinicians to prescribe effective antimicrobial drugs and prevent antibiotic resistance. It also helps in controlling healthcare costs by reducing inappropriate antibiotic use.
Weakness: Lack of standardized testing and reporting protocols can lead to errors and inconsistencies in results. High cost of automated systems is a barrier for small labs and clinics.
Opportunity: Growing prevalence of infectious diseases and rising antibiotic resistance is driving demand for rapid and accurate AST methods. Development of new Diagnostic methods like molecular tests provide opportunities.
Threats: Stringent regulatory approval process increases time to market new products. Alternative non-antimicrobial treatment options also pose a threat.
Key Takeaways
Global Antimicrobial Susceptibility Testing Market Size is expected to witness high growth. The global Antimicrobial Susceptibility Testing Market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030.
North America dominates the AST market currently due to high awareness, stringent regulations and presence of leading market players. Asia Pacific is expected to grow at fastest pace due to rising healthcare investments, economic growth and increasing prevalence of infectious diseases in developing countries.
Key players
Key players operating in the Antimicrobial Susceptibility Testing are Thermo Fisher Scientific Inc., Cytiva, Sartorius AG. Thermo Fisher Scientific Inc. offers comprehensive range of automated and rapid manual testing solutions.Cytiva provides VITEK automated AST systems along with diagnostic cards and software. Sartorius offers MICROSCAN WalkAway and RAPID MIC automated susceptibility testing systems.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
